Your browser doesn't support javascript.
loading
Successful salvage of primary progressive Hodgkin lymphoma with the combination of post-transplant brentuximab vedotin and radiotherapy: Combining novelty and tradition.
Belia, Marina; Chatzidimitriou, Chrysovalantou; Rondogianni, Phivi; Petsa, Panayiota; Efstathopoulou, Maria; Konstantinou, Eliana; Arapaki, Maria; Asimakopoulos, John; Plata, Eleni; Konstantopoulos, Kostas; Angelopoulou, Maria K; Vassilakopoulos, Theodoros P.
Affiliation
  • Belia M; Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.
  • Chatzidimitriou C; Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.
  • Rondogianni P; Department of Nuclear Medicine and PET/CT, Evangelismos General Hospital, Athens, Greece.
  • Petsa P; Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.
  • Efstathopoulou M; Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.
  • Konstantinou E; Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.
  • Arapaki M; Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.
  • Asimakopoulos J; Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.
  • Plata E; Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.
  • Konstantopoulos K; Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.
  • Angelopoulou MK; Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.
  • Vassilakopoulos TP; Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.
Hematol Oncol ; 39(2): 258-262, 2021 Apr.
Article in En | MEDLINE | ID: mdl-32905619
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy / Hodgkin Disease / Salvage Therapy / Stem Cell Transplantation / Brentuximab Vedotin Limits: Adult / Female / Humans / Male Language: En Journal: Hematol Oncol Year: 2021 Document type: Article Affiliation country: Greece
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy / Hodgkin Disease / Salvage Therapy / Stem Cell Transplantation / Brentuximab Vedotin Limits: Adult / Female / Humans / Male Language: En Journal: Hematol Oncol Year: 2021 Document type: Article Affiliation country: Greece